CXCR3 and neoplasm: CCL3,4,5 can indirectly promote effector T-cell recruitment by recruiting the DCs into tumor sites. Then, DC, in turn, recruits cytotoxic T cells into the tumor by producing CXCR3 ligands CXCL9 and CXCL10 (32, 33).